Evidence map›Paper›PMID 17917013›Full record

ReviewImmunologic research2007

Common variable immune deficiency: reviews, continued puzzles, and a new registry.

Charlotte Cunningham-Rundles, Adina Kay Knight

Abstract readReview
PubMed Publisher
In one paragraph

Review in Immunologic research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Immunoglobulin responses at the mucosal interface.Annual review of immunology · 2011
    Review
  9. Innate signals in mucosal immunoglobulin class switching.The Journal of allergy and clinical immunology · 2010
    Review
  10. Review
  11. Article
  12. Immunodeficiencies.Clinical and experimental immunology · 2009
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. The regulation of IgA class switching.Nature reviews. Immunology · 2008
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Charlotte Cunningham-RundlesDepartment of Medicine, Mount Sinai Medical Center, The Mount Sinai School of Medicine, New York, NY, USA. Charlotte.Cunningham-Rundles@mssm.edu
Adina Kay Knight
Icahn School of Medicine at Mount Sinai · USMount Sinai Medical Center · US

Funding

TARGETING PRIMARY IMMUNODEFICIENCY AMONG MINORITIESR18AI048693 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI CUNNINGHAM-RUNDLES, CHARLOTTE · 2000 to 2016
$6.2M
Exposporium determinants of Bacillus anthracisR21AI101093 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI STEWART, GEORGE C. · 2012 to 2013
$390k
NIAID NIH HHS AI 101093NIAID NIH HHS AI-467320NIAID NIH HHS AI-48693
6 · The paper itself

Abstract

backgroundCommon variable immune deficiency (CVID) is a clinically and immunologically heterogenous primary immune deficiency first described more than 50 years ago. The main features are hypogammaglobulinemia, recurrent infections, and other complications. While CVID is considered as a genetic immune defect, and several genes have been reported as leading to the CVID phenotype, one of the most puzzling features of CVID is the sporadic inheritance pattern and the relatively late onset. In most cases, no other family members have any immune defect. The mean age at diagnosis is between 25 and 45 years of age. These features suggest the interplay between either several or numerous genes with or without potential environmental factors.

Indexed as

RegistriesCommon Variable ImmunodeficiencyFemaleHumansMaleMiddle Aged

Identifiers

PMID17917013
OpenAlexW2070419269

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.